HCWB is trading 9.5% down at $2.20 as momentum cools following an extreme multi-day rally.
- Shares previously surged 129.25% on May 20 and over 260% on May 15, driven by positive CAR-T cell therapy research results and a significant Q1 2026 earnings beat.
- The current pullback reflects profit-taking in the thinly traded micro-cap as the recent speculative spike eases.